D-087-2013 Class II Terminated
FDA drug recall D-087-2013 was initiated by Genentech Inc on Sep 20, 2012 and is designated Class II. Reason for recall: Miscalibrated and/or Defective Delivery System: Genentech has received complaints for Nutropin AQ NuSpin 10 & 20 reporting that the dose knob spun slowly and the injection took longer than usual… The recall status is terminated (terminated Dec 24, 2013). Affected quantity: 10,306 syringes.
Recall Details
- Product Type
- Drugs
- Report Date
- Dec 12, 2012
- Initiation Date
- Sep 20, 2012
- Termination Date
- Dec 24, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 10,306 syringes
Product Description
Nutropin AQ NuSpin 20 (somatropin (rDNA origin) injection} 20 mg/ 2mL Genentech, South San Francisco, CA 94080, NDC#50242-0076-01
Reason for Recall
Miscalibrated and/or Defective Delivery System: Genentech has received complaints for Nutropin AQ NuSpin 10 & 20 reporting that the dose knob spun slowly and the injection took longer than usual (slow dose delivery).
Distribution Pattern
Nationwide
Code Information
Lot# 936674 Exp. 09/30/13
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-087-2013
- openFDA file date
- Nov 3, 2026
- Loaded by RegDataLab
- Nov 4, 2026